VHPB Centre for Evaluation of Vaccination (CEV) |
Executive Secretary Administrative and Scientific Secretariat |
privacy statement
|
14-15 March 2013 - Jerusalem, Israel
Thursday, March 14, 2013
Session 1 Introduction
Chair: Daniel Shouval, Pierre Van Damme
08.30 - 08.45
Session 2 The health care system in the country
Chair: Nedret Emiroglu, Emilia Anis
08.45 – 09.05
Organization of public health services in Israel. 1.5Mb (.pdf)
Emilia Anis, Director, Division of Epidemiology, Ministry of Health
09.05 – 09.25
Organization and funding of the Healthcare system
Gabi Bin-Nun, Department of Health Management, Ben-Gurion university, Beer Sheba
09.25 – 09.45
Treatment policies and access to treatment for chronic hepatitis B and C. 361Kb (.pdf)
Tal Morginstin, Director of the NLHS (National list of health services) Assessment Division at the Ministry of Health
09.45 – 10.05
National program for surveillance and control of viral hepatitis. 290Kb (.pdf)
Emilia Anis, Director, Division of Epidemiology, Ministry of Health
10.05 – 10.30 Discussion
10.30 – 10.50 Coffee Break
Session 3 Epidemiology of viral hepatitis in Israel
Chair: Françoise Roudot-Thoraval, Eli Zuckerman
10.50 – 11.10
Epidemiology of hepatitis A. 1.6Mb (.pdf)
Daniel Shouval, Liver Unit, Hadassah-Hebrew University, Jerusalem
11.10 – 11.30
Epidemiology of hepatitis B and C. 314Kb (.pdf)
Eli Zuckerman, Director, Liver Unit, Carmel Medical Center and Haifa and Western Galilee District, Clalit Health Services
11.30 – 11.50
Epidemiology of hepatitis E. 1.5Mb (.pdf)
Eli Schwartz, The Center for Travel Medicine and Tropical Diseases, Sheba Medical Center, Tel hashomer & Sackler School of Medicine Tel-Aviv Univ
11.50 – 12.00
Molecular epidemiology of hepatitis E. 230Kb (.pdf)
Nili Daudi, The Liver Unit, Hadassah-Hebrew University Hospital, Jerusalem
Session 4 Epidemiology of hepatitis virus in special risk groups
Chair: Paolo Bonanni, Oren Shibolet
12.00 – 12.20
Hepatitis B and C in pregnancy in the Jewish and Arab populations. 2.4 Mb (.pdf)
Rifaat Safadi, Director, Liver Unit, Hadassah Hebrew University Hospital, Jerusalem
12.20 – 12.40
HIV and HCV Co-infection. 1Mb (.pdf)
Margalit Lorber, Head, Autoimmune Disease Unit, Rambam Medical Center, Rappaport Faculty of Medicine, Technion, Haifa
12.40 – 13.00
Epidemiology of HCV and HIV infection in patients with coagulation disorders. 254Kb (.pdf)
Yaacov Maor, Dept. of Gastroenterology and Hepatology, Kaplan Medical Center, Rehovot
13.00 – 13.20
Hepatitis viruses and HIV in intra-venous drug abusers. 584Kb (.pdf)
Paula Roska, Head, Department for the Treatment Of Substance Abuse, MOH
13.20 – 13.30 Discussion
13.30 – 14.30 Lunch
Session 5 Prevention and Control of viral hepatitis in the country level
Chair: Mark Kane, Shmuel Rishpon
14.30 – 14.50
Prevention and control of HBV and HCV in healthcare workers. 785Kb (.pdf)
Bina Rubinowitch, Head, Unit of Infection Prevention and Control, Rabin Medical Center, Petah-Tikva
14.50 – 15.10
Sero-prevalence of HBs antibodies 19 years after introduction of universal vaccination against HBV. 591Kb (.pdf)
Tamar Shohat, Director, Israeli Center for Disease Control (ICDC), Ministry of Health
15.10 – 15.30
Prevention and control of hepatitis A and B in the Military
Michael Hartal, Head, Academy and Research Branch, Medical Corps, IDF
15.30 – 15.50
Screening for hepatitis B and C in Magen David Adom (MDA) - National Blood Services.
Vered Yahalom, Magen David Adom (MDA) - National Blood Services, Tel Hashomer
15.50 – 16.10 Discussion
16.10 – 16.30 Coffee Break
Session 6 Miscellaneous
Chair: Angela Dominguez, Rifaat Safadi
16.30 – 16.50
Evidence for a rising burden of hepatocellular carcinoma. 2Mb (.pdf)
Oren Shibolet, Director, Liver Unit, Tel-Aviv Medical Center
16.50– 17.10
Liver Transplantation for viral liver diseases in Israel. 270Kb (.pdf)
Michal Carmiel, Director, Liver Unit, Nahariya Medical Center
17.10 – 17.30
Patients Association: HETZ-The Israeli Association for the Health of the Liver. 1.9Mb (.pdf)
Julio Burman, The Israeli Association for the Health of the Liver, Kibbutz Tzora
17.30– 17.50 Discussion
Friday, March 15, 2013
Session 7 Vaccination programmes
Chair: John Ward, Daniel Shouval
09.00 – 09.20
The National Advisory Committee on Immunization and Infectious Diseases ( NACIID). 191Kb (.pdf)
Shmuel Rishpon, Head of the Advisory Committee on Infectious Diseases and Immunizations. Ministry of Health.
09.20 – 09.40
The national hepatitis A vaccination programme and the impact of universal immunization on the molecular epidemiology of HAV infection. 763Kb (.pdf)
Daniel Shouval, Liver Unit, Hadassah-Hebrew University'. Ron Dagan, BenGurion University, Beer Sheba
09.40 – 10.00
Hepatitis A in Jerusalem : An exception which proves the rule? 1.7Mb (.pdf)
Chen Stein-Zamir, MOH District Officer, Jerusalem
10.00 – 10.20
An outbreak of hepatitis A in adults in Tel-Aviv district. 1.6 Mb (.pdf)
Matthew Lewis, Tel-Aviv Health District
10.20– 10.40 Discussion
10.40 – 11.00 Coffee break
11.00– 11.40
Development and utilization of the PreS/S hepatitis B vaccine in Israel. Bypass of non-response to conventional immunization against HBV using a Pre-S/S vaccine. 4.8Mb (.pdf)
Daniel Shouval, Liver Unit, Hadassah-Hebrew University hospital, Jerusalem, Israel
11.40– 12.00
Hepatitis B vaccines in patients on hemodialysis.. 256Kb (.pdf)
Talia Weinstein, Head, Hemodialysis Unit, Tel Aviv Medical Center
12.00– 12.20
Concluding remarks on the prevention and control of viral hepatitis A, B and C in Israel 1972-2012. 190Kb (.pdf)
Daniel Shouval, Liver Unit, Hadassah-Hebrew University hospital, Jerusalem, Israel
12.20 – 12.40 Discussion
Session 8 Conclusions
Chair: Johannes Hallauer, Stefan Wiktor
13.00 – 13.45
Presentation of the VHPB meeting conclusions 67Kb(.pdf)
David FitzSimons
14.00 Close of the meeting